Clinical Trial Update: Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating magnesium iron hydroxycarbonate to reduce high blood phosphate in hemodialysis patients has completed; no efficacy or safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Failure

Drugs mentioned

• Magnesium iron hydroxycarbonate (magnesium iron hydroxycarbonate)

Snippet

Sponsor: Ineos Healthcare Limited | Conditions: Chronic Kidney Failure | Phase 2 | Status: COMPLETED